Recruiting nowNot applicable
TSBL-Based Versus BMI-Based Biliopancreatic Limb Length in One-Anastomosis Gastric Bypass
Updated 2026-09-01 · NCT07796503See eligibility →
Country
Clinical trials in Kazakhstan
Active obesity and GLP-1 studies with at least one location in Kazakhstan.
7active studies
5recruiting now
1countries represented
1largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowNot applicable
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Updated 2026-08-11 · NCT07728669See eligibility →
Recruiting nowNot applicable
The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
Updated 2026-05-07 · NCT07495020See eligibility →
Recruiting nowPhase 4
Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
Updated 2025-11-26 · NCT06410352See eligibility →
Recruiting nowNot applicable
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Updated 2025-07-11 · NCT06953180See eligibility →
Active, not recruitingNot applicable
Effect of a High-Protein Diet With Meal Replacements on Weight Loss
Updated 2026-05-06 · NCT07547722See eligibility →
Active, not recruitingNot applicable
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
Updated 2026-01-28 · NCT07303556See eligibility →
Related countries
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.